Lesage Benoît, Vannin Anne-Sophie, Emiliani Serena, Debaisieux Laurent, Englert Yvon, Liesnard Corinne
Fertility Clinic, Department of Obstetrics and Gynaecology and Laboratory for Research on Human Reproduction, Campus Erasme, Universite Libre de Bruxelles (ULB), Brussels, Belgium.
Fertil Steril. 2006 Jul;86(1):121-8. doi: 10.1016/j.fertnstert.2005.12.021. Epub 2006 Jun 6.
To develop a method for same-day validation of processed semen in the setting of assisted reproductive techniques (ART) with patients who are seropositive for human immunodeficiency virus, type 1 (HIV-1).
Laboratory experiments.
University hospital.
PATIENT(S): Volunteers who are HIV-1 seronegative and seropositive.
INTERVENTION(S): Evaluation of the sensitivity of a reverse-transcriptase (RT)-nested polymerase chain reaction (PCR) in HIV-1 RNA-positive blood plasma, in artificially infected blood plasma and semen, and in 85 semen samples of 29 HIV-1-seropositive volunteers. Semen was submitted to gradient separation, followed by swim-up.
MAIN OUTCOME MEASURE(S): Qualitative detection of HIV-1 RNA in blood plasma and in different parts of semen preparation by using RT-nested PCR, PCR inhibition control by dilution of samples, and an internal control.
RESULT(S): The detection limit of our PCR was 20 HIV-1 RNA copies per milliliter. Among seropositive patients, RNA was detected in 25% of fresh semen, 36.5% of seminal plasma, 27.5% of gradient supernatants, and 7.1% of final preparations before the migration-sedimentation stage. Positive final preparations were observed in patients who had blood viral loads of >/=20,000 HIV-1 RNA copies per milliliter. Inhibition was present in 17.6% of seminal plasma and in 20% gradient supernatants and in 2 final preparations among 69 tested. Among 25 preparations tested after the migration-sedimentation stage, 2 were positive (1 patient; 70,000 HIV-1 RNA copies per milliliter).
CONCLUSION(S): The RT-nested PCR detects low viral load and allows the validation of semen preparations of HIV-1-seropositive patients for ART on the day of sampling. For this purpose, the validation is performed on spermatozoa that are obtained after gradient separation before swim-up. Inhibition of the PCR must be controlled by using an internal control that is well-designed to explore the detection limit of the method.
开发一种方法,用于在辅助生殖技术(ART)背景下,对1型人类免疫缺陷病毒(HIV-1)血清学阳性患者的处理后精液进行当日验证。
实验室实验。
大学医院。
HIV-1血清学阴性和阳性的志愿者。
评估逆转录酶(RT)巢式聚合酶链反应(PCR)在HIV-1 RNA阳性血浆、人工感染血浆和精液以及29名HIV-1血清学阳性志愿者的85份精液样本中的敏感性。精液先进行梯度分离,然后进行上浮法处理。
通过RT巢式PCR定性检测血浆和精液制备不同部分中的HIV-1 RNA,通过样本稀释进行PCR抑制对照,并设置内部对照。
我们的PCR检测限为每毫升20个HIV-1 RNA拷贝。在血清学阳性患者中,新鲜精液中25%检测到RNA,精浆中36.5%检测到RNA,梯度上清液中27.5%检测到RNA,迁移沉降阶段前的最终制品中7.1%检测到RNA。血液病毒载量≥每毫升20,000个HIV-1 RNA拷贝的患者最终制品呈阳性。在检测的69份样本中,17.6%的精浆、20%的梯度上清液和2份最终制品存在抑制现象。在迁移沉降阶段后检测的25份制品中,2份呈阳性(1名患者;每毫升70,000个HIV-1 RNA拷贝)。
RT巢式PCR可检测低病毒载量,并能在采样当日对HIV-1血清学阳性患者的精液制品进行ART验证。为此,验证在梯度分离后、上浮法处理前获得的精子上进行。必须通过精心设计的内部对照来控制PCR的抑制作用,以探索该方法的检测限。